APEC1621 Pediatric MATCH Study - Clinical Trial
What is the Purpose of this Study?
We are doing this study to see if different study drugs or drug combinations that target specific genetic changes found in some cancers will shrink the tumor and/or prolong the time to progression.
Solid tumors, non-Hodgkin lymphomas, sarcoma, CNS tumors
Who Can Participate in the Study?
Children and adults with recurrent solid tumors, lymphoma, and CNS tumors who:
- Are aged 12 months to less than 21 years of age
- Have no uncontrolled infection
- Have had a prior solid organ transplant
What is Involved?
If you choose to join this study, you will:
- Have tumor tissue from a biopsy sent to a lab for genetic testing
-- If the tumor tissue has a genetic change that is targeted by one or more of the study drugs being tested in this study, you may be assigned to that study.